ProfileGDS4718 / 215024_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 62% 53% 45% 58% 55% 52% 57% 50% 57% 60% 53% 59% 53% 59% 53% 52% 50% 56% 53% 61% 50% 53% 47% 52% 56% 58% 53% 69% 57% 54% 50% 51% 50% 50% 60% 57% 51% 48% 52% 46% 55% 57% 57% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.2437762
GSM549102patient 115, normal, homogenized [OPG study]5.7022353
GSM549104patient 119, normal, homogenized [OPG study]5.2598645
GSM549108patient 138, normal, homogenized [OPG study]6.0508758
GSM549119patient 077, normal, homogenized [OPG study]5.8393455
GSM549133patient 032, cancer, homogenized [OPG study]5.6030952
GSM549139patient 042, cancer, homogenized [OPG study]5.8860257
GSM549099patient 107, normal, homogenized [OPG study]5.5199550
GSM549109patient 139, normal, homogenized [OPG study]5.9265557
GSM549110patient 046, normal, homogenized [OPG study]6.1129660
GSM549114patient 063, normal, homogenized [OPG study]5.6506253
GSM549122patient 082, normal, homogenized [OPG study]6.08559
GSM549134patient 033, cancer, homogenized [OPG study]5.6752653
GSM549136patient 036, cancer, homogenized [OPG study]6.0512459
GSM549140patient 044, cancer, homogenized [OPG study]5.6533353
GSM549111patient 047, normal, homogenized [OPG study]5.5912552
GSM549113patient 057, normal, homogenized [OPG study]5.4864450
GSM549132patient 031, cancer, homogenized [OPG study]5.871356
GSM549137patient 038, cancer, homogenized [OPG study]5.7006853
GSM549142patient 047, cancer, homogenized [OPG study]6.2477961
GSM549100patient 110, normal, homogenized [OPG study]5.5489650
GSM549107patient 135, normal, homogenized [OPG study]5.6752253
GSM549115patient 068, normal, homogenized [OPG study]5.2895547
GSM549116patient 072, normal, homogenized [OPG study]5.589652
GSM549120patient 078, normal, homogenized [OPG study]5.8689556
GSM549131patient 030, cancer, homogenized [OPG study]5.9453758
GSM549118patient 074, normal, homogenized [OPG study]5.709953
GSM549129patient 027, cancer, homogenized [OPG study]6.8794269
GSM549123patient 088, normal, homogenized [OPG study]5.9354957
GSM549124patient 006, cancer, homogenized [OPG study]5.7585154
GSM549126patient 015, cancer, homogenized [OPG study]5.4824450
GSM549128patient 025, cancer, homogenized [OPG study]5.5777151
GSM549103patient 117, normal, homogenized [OPG study]5.589650
GSM549117patient 073, normal, homogenized [OPG study]5.4820750
GSM549138patient 041, cancer, homogenized [OPG study]6.1551360
GSM549141patient 045, cancer, homogenized [OPG study]5.8951657
GSM549130patient 028, cancer, homogenized [OPG study]5.5744551
GSM549101patient 111, normal, homogenized [OPG study]5.4565548
GSM549105patient 128, normal, homogenized [OPG study]5.6740352
GSM549106patient 134, normal, homogenized [OPG study]5.2701746
GSM549112patient 048, normal, homogenized [OPG study]5.8091855
GSM549125patient 011, cancer, homogenized [OPG study]5.9435557
GSM549127patient 024, cancer, homogenized [OPG study]5.9889457
GSM549135patient 035, cancer, homogenized [OPG study]6.0107958